< Terug naar vorige pagina
Onderzoeker
Zhigang Wang
- Disciplines:Gastro-enterologie, Biofarmaceutica, Klinische farmacie, Farmacotherapie
Affiliaties
- Klinische Farmacologie en Farmacotherapie (Afdeling)
Lid
Vanaf1 mrt 2022 → Heden - Therapeutische en Diagnostische Antilichamen (Afdeling)
Lid
Vanaf1 mrt 2020 → 28 feb 2022
Projecten
1 - 1 of 1
- Een Farmacometrische Benadering ter Verbetering van Methoden voor Dosisindividualisatie van Biologische Geneesmiddelen in Patiënten met Chronische Inflammatoire ZiektenVanaf13 okt 2020 → HedenFinanciering: FWO Strategische Onderzoeksbeurs
Publicaties
1 - 8 van 8
- Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle(2024)
Auteurs: Zhigang Wang, Erwin Dreesen
Pagina's: 316 - 317 - Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation Study(2023)
Auteurs: Zhigang Wang, Bram Verstockt, João Guedelha Sabino, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
Pagina's: 3188 - 3190 - Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases(2022)
Auteurs: Wannee Kantasiripitak, Alex Kensert, Zhigang Wang, João Guedelha Sabino, Séverine Vermeire, Debby Thomas, Marc Ferrante, Erwin Dreesen
Pagina's: 1045 - 1059 - Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis(2022)
Auteurs: Rani Soenen, Zhigang Wang, Erwin Dreesen, Paul Declerck, Debby Thomas
Pagina's: 1324 - 1336 - Population pharmacokinetic-pharmacodynamic model-based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease(2022)
Auteurs: Zhigang Wang, Bram Verstockt, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante, Paul Declerck, Erwin Dreesen
Pagina's: 323 - 335 - Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases(2021)
Auteurs: Wannee Kantasiripitak, Zhigang Wang, Isabel Spriet, Marc Ferrante, Erwin Dreesen
Pagina's: 1455 - 1466 - Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis(2021)
Auteurs: Ruben Faelens, Zhigang Wang, Paul Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
- Therapeutic drug monitoring of anti-tumor necrosis factor agents : lessons learned and remaining issues(2020)
Auteurs: Zhigang Wang, Erwin Dreesen
Pagina's: 53 - 59